JPS58137756A - Deproteinization method of blood serum - Google Patents

Deproteinization method of blood serum

Info

Publication number
JPS58137756A
JPS58137756A JP2049182A JP2049182A JPS58137756A JP S58137756 A JPS58137756 A JP S58137756A JP 2049182 A JP2049182 A JP 2049182A JP 2049182 A JP2049182 A JP 2049182A JP S58137756 A JPS58137756 A JP S58137756A
Authority
JP
Japan
Prior art keywords
water
serum
protein
analysis
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2049182A
Other languages
Japanese (ja)
Inventor
Toshiyuki Doro
敏行 堂路
Yasuo Kashiwa
柏 康夫
Fumio Kamiyama
文男 神山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP2049182A priority Critical patent/JPS58137756A/en
Publication of JPS58137756A publication Critical patent/JPS58137756A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Abstract

PURPOSE:To remove protein which is a harmful material in analysis thoroughly and easily from a blood serum sample, by adding a water-soluble org. solvent to the serum to produce the precipitate of protein, then adding a water absorbent further thereto. CONSTITUTION:A water-soluble org. solvent is added to a blood serum which is required to be deproteinized in order to be subjected to analysis such as determination of medicines in blood, determination of traces of hormones in blood, etc. to allow protein to precipitate. A water absorbent is then added to a soln. mixture of the serum and the org. solvent, to force the water in the soln. to be absorbed in the absorbent, thereby removing the water in the soln. The protein dissolved in the water is deposited and settled by such removal of the water, and the serum is deproteinized thoroughly; therefore, the decrease in the analytic accuracy by the harmful material of the protein is prevented in the analysis to be executed thereafter.

Description

【発明の詳細な説明】 本発明は血清の分析に際しての血清除蛋白方法に関する
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for deproteinizing serum during serum analysis.

従来において、血清中よ)血中薬物濃度等の測定の障害
となる蛋白質を除去するには、有4Il&溶媒又はai
痢の添加によって蛋白質を沈澱させたのち、迫心分wA
禄作によって沈澱物を分離する方法が一般に行われてい
るが、この様な方法では、血清中の蛋白質を完全に除去
することが困難で、除蛋白された血清を液体クロマトグ
ラフ等によに分析する際に、残余の蛋白質が妨害物質と
して現われ、分析の精度が低下することが多い。
Conventionally, in order to remove proteins that interfere with the measurement of blood drug concentration (in serum), 4Il&solvent or ai
After precipitating the protein by adding diarrhea,
The commonly used method is to separate the precipitate by Rokusaku, but with this method, it is difficult to completely remove the proteins in the serum, and the protein-free serum is then separated using liquid chromatography. During analysis, residual proteins often appear as interfering substances, reducing the accuracy of analysis.

本発明は上記の加色従来の除蛋白方法の欠点にかんがみ
、除蛋白が完全にしかも簡便に行える方法を提供するこ
とを目的としてなされたものであシ、その要旨は、除蛋
白すべ急血清に、水可溶性の有機溶媒を加えることによ
り蛋白質の沈澱を生ぜしめたのち、さらに吸水剤を加え
ることを特徴とする血清除蛋白方法に存する。
In view of the drawbacks of the conventional color-adding protein removal methods, the present invention has been made with the aim of providing a method that can completely and easily perform protein removal. The present invention provides a serum protein removal method characterized by adding a water-soluble organic solvent to precipitate proteins, and then further adding a water-absorbing agent.

本発明における水溶性の有機溶媒とはいかなる量的関係
にあっても水に湿ける有機溶媒を意味し、具体的には例
えばメタノール、エタノール、l−プロパツール、2−
プロパツール、アリルアルコール#Oアルコール類、エ
チレングリコール、1.2−プロパンジオール、1.3
−プロパンジオールなどの多価アルコール類、エチレン
オキシド、プロピレンオキシド等のエーテル類、アセト
ン等のケトン類、ホルムアミド、ジメチルホルムアミド
等の酸アミド類、アセトニトリル等のニトリル類やジオ
キサン、テトラヒドロフランなどが挙けられる。
In the present invention, the water-soluble organic solvent refers to an organic solvent that can be wetted with water in any quantitative relationship, and specifically includes, for example, methanol, ethanol, l-propanol, 2-
Propatool, allyl alcohol #O alcohols, ethylene glycol, 1.2-propanediol, 1.3
Examples include polyhydric alcohols such as propanediol, ethers such as ethylene oxide and propylene oxide, ketones such as acetone, acid amides such as formamide and dimethylformamide, nitriles such as acetonitrile, dioxane, and tetrahydrofuran.

そして、これらめうち、アセトニトリル、アセトン、ジ
オキサン及びテトラヒドロフランがとくに好適に用いら
れる。
Of these, acetonitrile, acetone, dioxane and tetrahydrofuran are particularly preferably used.

又、本発@に用いられる吸水剤としては水分を吸収する
性貿を有1、用いられる有機溶媒に不溶のものが使用さ
れるが、その具体例として社、例えば欧化カルシウム、
酸化バリウム、酸化アルミニウム、五酸化リン、無水ホ
ウ酸、酸化マグネシウム、塩化カルシウム、憾鎗ナトリ
ウム、M化カルシウム、塩化マグネシウム、過塩素酸マ
グネシウム、過塩素酸バリウム、硫酸カルシウム、**
鋼、硫酸アルミニウム、縦酸カリウム、塩化亜fi8勢
が挙けられる。
In addition, the water-absorbing agent used in this product is one that absorbs water and is insoluble in the organic solvent used.
Barium oxide, aluminum oxide, phosphorus pentoxide, boric anhydride, magnesium oxide, calcium chloride, sodium chloride, calcium chloride, magnesium chloride, magnesium perchlorate, barium perchlorate, calcium sulfate, **
Examples include steel, aluminum sulfate, potassium chloride, and nitrous chloride.

本発明により除蛋白を行う対象は、血中薬物劇屋、血中
amホルモン測定等の分析を行うために除蛋白を行うこ
とが全景とされる血清であり、本発明にもとづいて除蛋
白を行うには、まず上記血清に前記有機溶媒を加えて血
清中の蛋白質を沈澱させるのである。有機溶媒の添加量
線、血ml答量に対し、後に加える吸水剤の種類にもよ
るが、1容量以上とするのが好ましい。
The subject of protein removal according to the present invention is serum, which is generally required to be subjected to protein removal for analysis such as blood drug therapy and blood am hormone measurement. To do this, first, the organic solvent is added to the serum to precipitate the proteins in the serum. Although it depends on the type of water-absorbing agent to be added later, it is preferable to set the volume to 1 volume or more based on the addition amount line of the organic solvent and the blood ml volume.

次に前記吸水剤を血清と有機溶媒の混合AI液液中加え
、該溶液中の水分を吸水剤Klk収させ、溶液中の水分
を除去するのである。この水分の除去によって、水分に
溶けていた蛋白質が析出して沈澱し、血清の除蛋白が完
全に行われるのであり、従ってその後に行われる分析に
おいて、蛋白質の妨害物質によって分析精度が低下する
ということがなくなるのである。
Next, the water absorbing agent is added to the mixed AI liquid of serum and an organic solvent, and the water in the solution is absorbed by the water absorbing agent Klk, thereby removing the water in the solution. By removing this water, the proteins dissolved in the water precipitate out and the serum is completely deproteinized.Therefore, in the subsequent analysis, the accuracy of the analysis is reduced due to protein interfering substances. That will no longer be the case.

なお、吸水剤の使用−としては血清中の水分を吸収する
に十分な電とすればよく、その使用瀘は特に限定される
こと社ない。
Note that the water-absorbing agent may be used as long as it has enough electricity to absorb the water in serum, and there are no particular restrictions on how it can be used.

又、本発明によって除蛋白された血清試料を分析のため
に取り出すには、遠心分離等の過室な手法により、溶赦
部と沈澱物、吸水剤醇の固形物とに分離してもよく、又
社吸水剤が加えられた混合液を静置して沈澱物等を沈降
させ上階液を採取してもよい。
Furthermore, in order to take out the serum sample from which protein has been removed according to the present invention for analysis, it may be separated into a dissolved part, a precipitate, and a solid substance in the water-absorbing agent by using an intensive method such as centrifugation. Alternatively, the liquid mixture to which the water-absorbing agent has been added may be allowed to stand to allow the precipitate to settle, and then the upper liquid may be collected.

上述の様に、本発明血清除蛋白方法は、除蛋白すべき血
清に、水可溶性の有機溶媒を加えることKより蛋白質の
沈澱を生ぜしめたのち、さらに吸水剤を加えることを特
徴とするので、血清試料から分析における妨害物質たる
蛋白質が完全にしかも簡便に除去され、その結果、分析
精度の向上をもたらすというすぐれた効果を奏するので
ある。
As mentioned above, the serum protein removal method of the present invention is characterized by adding a water-soluble organic solvent to the serum to be protein-removed to cause protein precipitation, and then further adding a water-absorbing agent. Proteins, which are interfering substances in analysis, are completely and easily removed from the serum sample, resulting in an excellent effect of improving the accuracy of analysis.

以下本発明の実施例について説明する。Examples of the present invention will be described below.

実施例及び比較例 抗テンカン薬プリミドン及びエトサクシミドを富む血清
0.2dに水溶性有機溶媒アセトニトリル0.4−を加
え、皺血清中の蛋白質の沈澱を生成させたのち、さらに
吸水剤として無水硫酸ナトリウム0.22を加えて振と
うし、静置した。
Examples and Comparative Examples 0.4 d of a water-soluble organic solvent acetonitrile was added to 0.2 d of serum rich in the anti-temperature drugs primidone and ethosuximide to form a precipitate of proteins in the wrinkled serum, and then anhydrous sodium sulfate was added as a water-absorbing agent. 0.22 was added, shaken, and allowed to stand still.

上置液を採取し、咳装置液中の水溶性蛋白質の童を7エ
ノール試薬法により測定した所、その含有量は25メf
/−以下であった。
When the supernatant fluid was collected and the amount of water-soluble protein in the cough device fluid was measured using the 7-enol reagent method, the content was found to be 25 mef.
/- or less.

父、上記上置液を、4.61径X25(1mのカラム(
商品名ZORBAX−OD8.デュボ/社製)がセット
された^速液体り四マドグラフによシ、溶離液として3
5チアセトニトリル水溶液 (流速、1.3j/*)を
用い、UV−UV−210n紫外線検出で分析した所、
プリミドン及びエトサクシミドの明確なピークが得られ
、これら抗テンカン薬の定量が出来だ。
My father, put the above liquid into a 4.61 diameter x 25 (1 m column)
Product name ZORBAX-OD8. Dubo Co., Ltd.) was set on the fast liquid RI4 MADROGRAPH, and 3 was used as the eluent.
Analyzed by UV-UV-210n ultraviolet detection using 5-thiacetonitrile aqueous solution (flow rate, 1.3j/*),
Distinct peaks of primidone and ethosuximide were obtained, and the quantification of these anti-tencan drugs was possible.

一方、比較のために、抗テンカン薬プリミドン及びエト
サクシミドを含む血清0.21にアセトニトリル0.4
 sifを加えて蛋白質を生成させた血清試料から採取
した上置液について、フェノール試薬法により測定した
がその結果、練上11!を液中に水溶性蛋白質が500
メF/−以上含まれていることが判明した。父、該上置
液について、上記実施例と同様にして高連箪体クロマト
グラフによる分析を行ったが、水溶性蛋白質が妨害成分
として溶出し、該成分のピークがプリミドン及びエトサ
クシミドのピークと重なってこれら抗テンカン薬の定量
は不可能であった。
On the other hand, for comparison, acetonitrile 0.4 was added to 0.21 serum containing anti-temperature drugs primidone and ethosuximide.
The supernatant solution collected from the serum sample in which sif was added to produce protein was measured using the phenol reagent method, and the result was 11! 500% water-soluble protein in the liquid
It was found that it contained more than F/-. The above solution was analyzed by high-pressure column chromatography in the same manner as in the above example, but water-soluble protein was eluted as an interfering component, and the peak of this component overlapped with the peaks of primidone and ethosuximide. Therefore, it was not possible to quantify these anti-depressant drugs.

特許出願人 積水化学工業株式会社 代表者  藤  沼  基  利patent applicant Sekisui Chemical Co., Ltd. Representative: Mototoshi Numa

Claims (1)

【特許請求の範囲】[Claims] 1、 除蛋白すべ龜血情に、水可溶性の有機溶媒を加え
ることKより蛋白質O沈厳を生ぜしめたのち、さらに吸
水剤を加えることを特徴とする血清除蛋白方法。
1. A serum protein removal method characterized by adding a water-soluble organic solvent to the protein removal serum to cause protein O precipitation, and then further adding a water-absorbing agent.
JP2049182A 1982-02-09 1982-02-09 Deproteinization method of blood serum Pending JPS58137756A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2049182A JPS58137756A (en) 1982-02-09 1982-02-09 Deproteinization method of blood serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2049182A JPS58137756A (en) 1982-02-09 1982-02-09 Deproteinization method of blood serum

Publications (1)

Publication Number Publication Date
JPS58137756A true JPS58137756A (en) 1983-08-16

Family

ID=12028615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2049182A Pending JPS58137756A (en) 1982-02-09 1982-02-09 Deproteinization method of blood serum

Country Status (1)

Country Link
JP (1) JPS58137756A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009008610A (en) * 2007-06-29 2009-01-15 Toshiba Corp Microchemical analyzer, its measuring method, and test sample picking device
JP2013011624A (en) * 2012-10-02 2013-01-17 Toshiba Corp Test specimen collecting tool

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009008610A (en) * 2007-06-29 2009-01-15 Toshiba Corp Microchemical analyzer, its measuring method, and test sample picking device
JP2013011624A (en) * 2012-10-02 2013-01-17 Toshiba Corp Test specimen collecting tool

Similar Documents

Publication Publication Date Title
Rashid et al. Preliminary evaluation of a molecular imprinted polymer for solid-phase extraction of tamoxifen
Kanimozhi et al. Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography–mass spectrometry for the determination of estrogens in ovarian cyst fluid samples
JPS6147132B2 (en)
Carson Ion-pair solid-phase extraction
Cuisinaud et al. Determination of nalidixic acid and its two major metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography
Laganà et al. General and selective isolation procedure for high-performance liquid chromatographic determination of anabolic steroids in tissues
Gill et al. Analysis of barbiturates in blood by high-performance liquid chromatography
Bakircioglu et al. Concentration of cadmium, copper and zinc using water soluble polyacrylic acid polymer
Tokman et al. Preconcentration and separation of copper (II), cadmium (II) and chromium (III) in a syringe filled with 3-aminopropyltriethoxysilane supported on silica gel
Ogata et al. Measurement of chloral hydrate, trichloroethanol, trichloroacetic acid and monochloroacetic acid in the serum and the urine by gas chromatography
JPS58137756A (en) Deproteinization method of blood serum
Gosink Rapid simultaneous determination of picogram quantities of aluminum and chromium from water by gas phase chromatography
Reid Sample preparation in the micro-determination of organic compounds in plasma or urine. A review
L'emeillat et al. Quantitative gas chromatographic determination of low-molecular-weight straight-chain carboxylic acids as their p-bromophenacyl esters after extractive alkylation in acidic medium
Guo et al. Alkyl thiourea functionalised silica for the effective removal of heavy metals from acanthopanax senticosus extract
Lau et al. Solid‐phase extraction for oil and grease analysis
Ford et al. A rapid extraction method for acidic drugs in hemolyzed blood
US6156431A (en) Extraction material comprising treated silica and method for determination of gamma-hydroxybutyrate
Moral et al. Application of a homemade silica-based mixed-mode ion-exchange sorbent for the determination of drugs in environmental water samples
Beasley et al. Liquid chromatographic system for separating opium alkaloids
CN108828114A (en) A kind of method of solid phase microextraction-mass spectrometry on-line preconcentration detection Performance Liquid Chromatography Analysis for Nicotine in Tobacco class compound
Manhas et al. Molecularly imprinted polymer-based dispersive solid-phase extraction for the selective determination of carisoprodol in biological and pharmaceutical samples
Rao Gajula et al. Green bioanalysis: an innovative and eco-friendly approach for analyzing drugs in biological matrices
JP2792038B2 (en) Analysis method and pretreatment method for sample in which water-soluble polymer substance and low-molecular component coexist, and filler for chromatography
Cecair et al. Agarose-chitosan-intergrated multiwalled carbon nanotubes film solid phase microextraction combined with high performance liquid chromatography for the determination of tricyclic antidepressant drugs in aqueous samples